AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bull, U
Schober, O
Osieka, R
Citation: U. Bull et al., Advances in surgery - Without advances in medical technology?, DEUT MED WO, 126(42), 2001, pp. 1188-1189
Authors:
Cremerius, U
Fabry, U
Neuerburg, J
Zimny, M
Bares, R
Osieka, R
Bull, U
Citation: U. Cremerius et al., Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma, NUKLEARMED, 40(1), 2001, pp. 23-30
Authors:
Efferth, T
Futscher, BW
Osieka, R
Citation: T. Efferth et al., 5-azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs, BL CELL M D, 27(3), 2001, pp. 637-648
Authors:
Efferth, T
Fabry, U
Osieka, R
Citation: T. Efferth et al., DNA damage and apoptosis in mononuclear cells from glucose-6-phosphate dehydrogenase-deficient patients (G6PD Aachen variant) after UV irradiation, J LEUK BIOL, 69(3), 2001, pp. 340-342
Authors:
Maywald, O
Galm, O
Fabry, U
Kohne, E
Osieka, R
Citation: O. Maywald et al., Uncommon cause of polycythemia in a pregnant female, MED KLIN, 96(1), 2001, pp. 45-49
Authors:
Efferth, T
Fabry, U
Osieka, R
Citation: T. Efferth et al., Induction of apoptosis, depletion of glutathione, and DNA damage by extracorporeal photochemotherapy and psoralen with exposure to UV light in vitro, ANTICANC R, 21(4A), 2001, pp. 2777-2783
Authors:
Osieka, R
Citation: R. Osieka, Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy, STRAH ONKOL, 177(6), 2001, pp. 319-320
Authors:
Galm, O
Fabry, U
Adam, G
Osieka, R
Citation: O. Galm et al., Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment, DIGESTION, 64(2), 2001, pp. 128-132
Authors:
Efferth, T
Osieka, R
Beutler, E
Citation: T. Efferth et al., Molecular characterization of a German variant of glucose-6-phosphate dehydrogenase deficiency (G6PD Aachen), BL CELL M D, 26(1), 2000, pp. 101-104
Authors:
Galm, O
Fabry, U
Osieka, R
Citation: O. Galm et al., Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide, LEUKEMIA, 14(2), 2000, pp. 343-344
Authors:
Efferth, T
Fabry, U
Osieka, R
Citation: T. Efferth et al., Damage of the kinesin heavy chain gene contributes to the antagonism of cisplatin and paclitaxel, ANTICANC R, 20(5A), 2000, pp. 3211-3219
Authors:
Efferth, T
Fabry, U
Osieka, R
Citation: T. Efferth et al., Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity, ANTICANC R, 20(4), 2000, pp. 2541-2546
Authors:
Cremerius, U
Fabry, U
Kroll, U
Zimny, M
Neuerburg, J
Osieka, R
Bull, U
Citation: U. Cremerius et al., Clinical value of FDG-PET for therapy monitoring of malignant lymphoma - Results of a retrospective study in 72 patients, NUKLEARMED, 38(1), 1999, pp. 24-30
Authors:
Cremerius, U
Fabry, U
Neuerburg, J
Zimny, M
Osieka, R
Buell, U
Citation: U. Cremerius et al., Positron emission tomography with F-18-FDG to detect residual disease after therapy for malignant lymphoma, NUCL MED C, 19(11), 1998, pp. 1055-1063
Risultati:
1-14
|